Nanoassay development
National Heart, Lung, And Blood Institute
Investigators
Linked publications & trials
Abstract
Fluorescence Spectroscopy is inherently a very sensitive technique; it already forms the basis of most non-radioactive real time assays like PCR. Our lab previously collaborated with former fellows (now in biotech industry) to develop alternatives to PCR like "CataCleave" probes for SNPs. We continue to study the photophysics and proper coupling of DNA components to carriers such as multilayer metal nanoparticles for much faster PCR analysis and the use of FCS (see MPM report) to quantify very tight protein-protein and protein-DNA binding in sub-microliter drops (analytes are present in sub-femtomole amounts). We are presently designing STAQ probes (see nanoscopy project) for DNA/RNA probing, analagous to catacleave, in plans to only superresolve tight binding sites. Recently we have used TCSPC to begin untangling designed aptamer heterogeneity questions (see MPM project and TR project). Aptamers can combine their turn-on fluorescence with analyte detection, so we have begun developing various FRET sensing concepts for RNA. We also continued to study the signatures for peptide and DNA "Excitonic" probes that self-quench unless unfolded or cleaved, in collaboration with local industry and most recently in aptamer collaborations ; excitonic coupling has value in the nascent quantum optics (communication esp.) field. Collaborative efforts have been unfortunately inhibited by limited on-site presence.
View original record on NIH RePORTER →